As of 2025-07-01, the Fair Value of Nurix Therapeutics Inc (NRIX) is -13.67 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 11.71 USD, the upside of Nurix Therapeutics Inc is -216.72%.
With the market price of 11.71 USD and our fair value calculation, Nurix Therapeutics Inc (NRIX) is not a good investment. Investing in NRIX stocks now will result in a potential loss of 216.72%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-11-30 | 2021-11-30 | 2022-11-30 | 2023-11-30 | 2024-11-30 | 5Y Avg | |
| Net income | -43.24 | -117.19 | -180.36 | -143.95 | -193.57 | -135.66 |
| YoY growth | -99.26% | -171.02% | -53.90% | 20.19% | -34.47% | -67.69% |
| Market Cap (mil) | 892.77 |
| P/E | |
| Forward P/E |
| EPS | -2.73 |
| Avg earnings growth rate | -67.69% |
| TTM earnings | -208.40 |